Novavax, Inc. (NASDAQ:NVAX) announced that it will host a conference call and webcast to report its fourth quarter and year-end 2013 financial results on Monday, March 10, 2014, at 4:30 p.m. ET. Novavax, Inc. (NASDAQ:NVAX) dropped -5.02 percent to $6.05 yesterday on volume of 4.36 million shares. The intra-day range of the stock was $5.86…
On Jan 19, FireEye, Inc. (NASDAQ:FEYE) announced that it has been awarded the UK Government’s new Cyber Essentials Scheme accreditation. Part of the UK Government’s National Cyber Security Strategy, the Cyber Essentials Scheme is an independent analysis and recommendation of the necessary security controls for mitigating risks from the latest cyber threats. FireEye, Inc. (NASDAQ:FEYE)…
Shares of ZIOPHARM Oncology (NASDAQ:ZIOP) saw a significant decrease in short interest in December. As of December 15th, there was short interest totalling 17,601,779 shares, a decrease of 5.8% from the November 28th total of 18,695,183 shares, AnalystRatingsNetwork.com reports. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) belongs to Healthcare sector. Its weekly performance is 8.10%. On last trading…
On Nov 04, FireEye, Inc. (NASDAQ:FEYE) reported a third quarter non-GAAP loss of $0., with revenues of $114.2 million. Analysts expected a loss of $0.56 and revenues of $116.02 million. The company expects to report a fourth quarter loss of $0.50 to $0.46 and between $2.15 and $2.05 for the full year. The consensus estimates…
